Aberdeen scientists have been instrumental in the discovery and commercialisation of an entirely new drug for the treatment of Alzheimer’s disease.

Professor Claude Wischik and his group discovered the first compounds to prevent accumulation of a brain protein called tau, a process associated with the onset of Alzheimer’s disease and other degenerative diseases of the brain.

In this short video, Dr Charlie Harrington describes the progress we have made in the development of a new drug for the treatment of Alzheimer’s disease.

свернуть